Extracorporeal Life Support: Four Decades and Counting

被引：7
作者：
Alibrahim O.S. [1 ]
Heard C.M.B. [2 ]
机构：
[1] Department of Pediatrics, Division of Pediatric Critical Care, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo Women & Children’s Hospital of Buffalo, 219 Bryant Street, Buffalo, 14222, NY
[2] Department of Anesthesiology Division of Pediatric Critical Care Medicine, Women & Children’s Hospital of Buffalo, 219 Bryant Street, Buffalo, 14222, NY
来源：
Current Anesthesiology Reports | 2017年 / 7卷 / 2期
关键词：
ARDS; Cardiac ECLS; Congenital diaphragmatic hernia; Double lumen cannula; ECLS; ECMO; Extracorporeal life support; Extracorporeal membrane oxygenation; Internal jugular vein; Respiratory failure; Venoarterial; Venovenous;
D O I：
10.1007/s40140-017-0210-0
中图分类号：
学科分类号：
摘要：
Extracorporeal membrane oxygenation (ECMO) or extracorporeal life support (ECLS) is a form of heart lung bypass that is used to support neonates, pediatrics, and adult patients with cardiorespiratory failure for days or weeks till organ recovery or transplantation. Venoarterial (VA) and venovenous (VV) ECLS are the most common modes of support. ECLS circuit components and monitoring have been evolving over the last 40 years. The technology is safer, simpler, and more durable with fewer complications. The use of neonatal respiratory ECLS use has been declining over the last two decades, while adult respiratory ECLS is growing especially since the H1N1 influenza pandemic in 2009. This review provides an overview of ECLS evolution over the last four decades, its use in neonatal, pediatric and adults, description of basic principles, circuit components, complications, and outcomes as well as a quick look into the future. © 2017, Springer Science + Business Media New York.
引用
收藏
页码：168 / 182
页数：14
相关论文
共 130 条
[1]  
Rais-Bahrami K., van Meurs K.P., Et al., Venoarterial versus venovenous ECMO for neonatal respiratory failure, Semin Perinatol, 38, 2, pp. 71-77, (2014)
[2]  
Bartlett R.H., Gazzaniga A.B., Jefferies M.R., Huxtable R.F., Haiduc N.J., Fong S.W., Et al., Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy, ASAIO J, 22, 1, pp. 80-92, (1976)
[3]  
Bartlett R.H., Andrews A.F., Toomasian J.M., Haiduc N.J., Gazzaniga A.B., Et al., Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases, Surgery, 92, 2, pp. 425-433, (1982)
[4]  
Gray B.W., Haft J.W., Hirsch J.C., Annich G.M., Hirschl R.B., Bartlett R.H., Et al., Extracorporeal life support: experience with 2000 patients, ASAIO journal (American Society for Artificial Internal Organs: 1992), 61, 1, (2015)
[5]  
Dalton H.J., Et al., Extracorporeal life support: moving at the speed of light, Respiratory Care September, 56, 9, pp. 1445-1456, (2011)
[6]  
Lequier L., Et al., Extracorporeal life support in pediatric and neonatal critical care: a review, J Intensive Care Med, 19, 5, pp. 243-258, (2004)
[7]  
Gibbon J.H., Et al., Application of a mechanical heart and lung apparatus to cardiac surgery, Minn Med, 37, 3, (1954)
[8]  
Clowes G.H., Hopkins A.L., Neville W.E., Et al., An artificial lung dependent upon diffusion of oxygen and carbon dioxide through plastic membranes, J Thorac Surg, 32, 5, pp. 630-637, (1956)
[9]  
Kammermeyer K., Et al., Silicone rubber as a selective barrier, Industrial & Engineering Chemistry, 49, 10, pp. 1685-1686, (1957)
[10]  
Kolobow T., Zapol W., Pierce J.E., Keeley F., Replogle R.L., Haller A., Et al., Partial extracorporeal gas exchange in alert newborn lambs with a membrane artificial lung perfused via an AV shunt for periods up to 96 hours, ASAIO J, 14, 1, pp. 328-334, (1968)
12345678910